Publications by authors named "Kevin Abney"

Claim this Profile
S
S100A6 is a positive regulator of PPP5C-FKBP51-dependent regulation of endothelial calcium signaling.
Barnita Haldar, Caleb L Hamilton, Viktoriya Solodushko, Kevin A Abney, Mikhail Alexeyev

FASEB J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.
Brandon M D'Arcy, Mark R Swingle, Cinta M Papke, Kevin A Abney, Erin S Bouska

Mol Cancer Ther· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PP1:Tautomycetin Complex Reveals a Path toward the Development of PP1-Specific Inhibitors.
Meng S Choy, Mark Swingle, Brandon D'Arcy, Kevin Abney, Scott F Rusin

J Am Chem Soc· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serine/threonine phosphatase 5 (PP5C/PPP5C) regulates the ISOC channel through a PP5C-FKBP51 axis.
Caleb L Hamilton, Kevin A Abney, Audrey A Vasauskas, Mikhail Alexeyev, Ni Li

Pulm Circ· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.
Debasish Chattopadhyay, Mark R Swingle, Edward A Salter, Eric Wood, Brandon D'Arcy, Kevin Abney

Biochem Pharmacol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis